Auranofin [auranofin]
- Terms
-
Crisinor
Ridaura
Ridauran
SK&F D 39162
SK&F-39162
An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
- DUI
- D001310 MeSH Browser
- CUI
- M0001971
- CAS
- Gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-
- Previous indexing
- Gold (1966-1974); Gold Thioglucose/analogs & derivatives (1975-1986)
- History note
- 87
- Public note
- 87
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 1
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 3
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 3
- TO
- toxicity 0
- UR
- urine 0